Compare
5 stocks, side by sideRelative performance · rebased to 100
GILDPFEAMGNNVOBMY
| GILDGilead Sciences | PFEPfizer | AMGNAmgen | NVONovo Nordisk A/S | BMYBristol Myers Squibb | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | 7/10 | 9/10 | 9/10 | 9/10 |
| Price | $125.16 | $24.04 | $351.43 | $47.64 | $55.00 |
| 1 month | -6.2% | -7.2% | +3.6% | +7.8% | -7.5% |
| 1 year | +21% | +7.0% | +33% | -29% | +23% |
| 5 year | +123% | -21% | +72% | +28% | +0.48% |
| P/E (TTM) | 16.9 | 18.2 | 24.3 | 1.3 | 15.4 |
| P/E vs sector | - | - | - | -96% | - |
| Market cap | $153.7B | $143.7B | $182.2B | $210.9B | $110.3B |
| Sector | Health Care | Health Care | Health Care | Healthcare | Health Care |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.